about
Exploring the impact of BDNF Val66Met genotype on serotonin transporter and serotonin-1A receptor bindingImaging treatment effects in depression.Increased neural habituation in the amygdala and orbitofrontal cortex in social anxiety disorder revealed by FMRI.Effects of Silexan on the serotonin-1A receptor and microstructure of the human brain: a randomized, placebo-controlled, double-blind, cross-over study with molecular and structural neuroimaging.Disrupted effective connectivity between the amygdala and orbitofrontal cortex in social anxiety disorder during emotion discrimination revealed by dynamic causal modeling for FMRIDifferential modulation of the default mode network via serotonin-1A receptorsHigh-Dose Testosterone Treatment Increases Serotonin Transporter Binding in Transgender People.Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET.RESCALE: Voxel-specific task-fMRI scaling using resting state fluctuation amplitude.High-resolution functional MRI of the human amygdala at 7 TEffects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression.Neurotransmitters and electroconvulsive therapy.Effects of hormone replacement therapy on cerebral serotonin-1A receptor binding in postmenopausal women examined with [carbonyl-¹¹C]WAY-100635.The influence of the rs6295 gene polymorphism on serotonin-1A receptor distribution investigated with PET in patients with major depression applying machine learning.A New Prediction Model for Evaluating Treatment-Resistant Depression.Epidemiology and socioeconomic impact of seasonal affective disorder in Austria.The combined effect of genetic polymorphisms and clinical parameters on treatment outcome in treatment-resistant depression.Impact of COMT genotype on serotonin-1A receptor binding investigated with PET.Cerebral serotonin transporter asymmetry in females, males and male-to-female transsexuals measured by PET in vivo.Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET.Psychiatric patients' perception of physical restraint.Use of Light Therapy by Office-Based Physicians.Combining image-derived and venous input functions enables quantification of serotonin-1A receptors with [carbonyl-11C]WAY-100635 independent of arterial sampling.Serotonin-1A receptor binding is positively associated with gray matter volume -- a multimodal neuroimaging study combining PET and structural MRI.Relation of progesterone and DHEAS serum levels to 5-HT1A receptor binding potential in pre- and postmenopausal women.Application of image-derived and venous input functions in major depression using [carbonyl-(11)C]WAY-100635.Gray matter and intrinsic network changes in the posterior cingulate cortex after selective serotonin reuptake inhibitor intake.Actigraphy in patients with treatment-resistant depression undergoing electroconvulsive therapy.Interaction between 5-HTTLPR and 5-HT1B genotype status enhances cerebral 5-HT1A receptor binding.Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression.Impact of electroconvulsive therapy on 5-HT1A receptor binding in major depression.Case ReportHormonersatztherapie und deren Wirkung auf Psyche und Gehirn
P50
Q34134231-7B3DEE06-2118-44FD-864A-F38CF1CF55E9Q34323653-4C7AF058-F82F-4884-9C01-836B2749BA77Q34499908-5D96B7FD-2583-438A-92EB-B4F3FCEC7439Q35178976-AABC9011-8BDA-49FF-88D3-B1493C8971F8Q35233882-82E1AA39-A266-4FFA-A061-FA625BB7FC2CQ35787090-10BF899D-32F5-480E-938C-E0C98D432105Q36098853-3A59A2CE-3497-48E1-9D91-B07A1E6D501CQ36479050-A5E1D19D-ACE7-490B-82F9-D3810B6AAF6EQ36665425-D60DDFA4-18D4-446D-A4F7-3687EF465E53Q36775784-67385B50-905B-416D-9537-47E220362EFDQ37625437-73D6555C-CF5F-4916-9234-2EC155E01D17Q38211334-E8F14CBC-4601-4225-A687-91BBE08B2847Q38430002-9073B086-B6B7-4788-8BF8-D29ADBA9699BQ38671559-6E46F64C-2035-44FE-88F8-5933E585C54FQ39031510-8E07C134-ADDD-419D-9273-26DE2529DB2AQ40069755-87816EC8-50B5-4D75-9784-EDD3F0660974Q41225938-47EC5D6D-CBC7-44AD-9314-7B618973EB07Q43706844-5084614C-B344-4E33-896E-37F19FF751AAQ44376668-28C58480-8DAE-4DAF-802C-C7C0D367877DQ44593909-8DB88C05-43B3-4DEF-B54A-EB0DBEEBC8F4Q47631715-F910D686-E66D-4F07-83D9-C768504CA80AQ47717926-2253E660-797A-40C3-8C6D-D7F6B11FB29DQ47774982-4F71A8B5-3C8D-4F68-9FAE-C79D3E65A538Q48637684-E5481F47-CD50-491A-8F8D-8131517B1008Q48745898-31594242-BE09-4D42-AF5D-86B710D7F0B7Q49011429-4A3A32BF-70A0-4773-A6D4-243BDBFF28A6Q49101485-4811FA39-9689-4C27-89EB-8949A692A649Q50049749-CB415A05-BC00-4C51-8B0A-9D1024D4E768Q51059359-B6DB4EC5-B6AB-4664-8D1E-8BB2DF43A6F2Q53082709-F01619A7-7C0B-4918-A94F-3BAC8170AEEEQ53128023-51D4F8D1-BF41-486C-9E7D-618F129F5954Q57737775-1BD9D7DD-07D4-4BD3-AECA-3921768721FFQ57738197-8101E62F-F683-4914-A039-975D9968A450
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Pia Baldinger
@ast
Pia Baldinger
@en
Pia Baldinger
@es
Pia Baldinger
@nl
Pia Baldinger
@sl
type
label
Pia Baldinger
@ast
Pia Baldinger
@en
Pia Baldinger
@es
Pia Baldinger
@nl
Pia Baldinger
@sl
altLabel
Pia Baldinger
@en
prefLabel
Pia Baldinger
@ast
Pia Baldinger
@en
Pia Baldinger
@es
Pia Baldinger
@nl
Pia Baldinger
@sl
P106
P1153
57148482200
P21
P2456
P31
P496
0000-0001-8382-6665
P569
2000-01-01T00:00:00Z